Botulax 200 Units Injection is a prescription-only injectable biological product containing Botulinum Toxin Type A. It is supplied as a sterile, lyophilized formulation intended strictly for professional and institutional use within regulated medical environments. AmeriDrugs offers this product exclusively for international pharmaceutical export and institutional supply, aligned with global compliance standards. Active Ingredient Botulinum Toxin Type A – 200 Units (IU) per vialBotulinum Toxin Type A is a highly purified neurotoxin protein used in controlled clinical and therapeutic settings under approved regulatory frameworks. Therapeutic UseFrom an informational and regulatory perspective, Botulax 200 Units Injection is supplied to licensed healthcare institutions for use in approved therapeutic and procedural applications, subject to the laws and approvals of the importing country. This content is provided strictly for product identification and trade-related purposes. AmeriDrugs does not provide medical advice, clinical protocols, or patient-level guidance. Dosage Form Sterile lyophilized powder for injection Supplied in single-use glass vials suitable for professional reconstitution Method of preparation and administration is determined exclusively by qualified medical professionals in accordance with local regulatory requirements Quality & Manufacturing StandardsBotulax 200 Units Injection is manufactured in GMP-certified facilities following stringent biological production and quality assurance systems. Each batch undergoes validated testing for sterility, potency, purity, and stability to meet international pharmaceutical and export-market standards. Packaging Information Pharmaceutical-grade glass vial with rubber stopper and aluminum seal Protective secondary packaging designed for international shipment and cold-chain compliance, where applicable Export packaging formats may be adapted based on importer and regulatory specifications Target BuyersThis product is intended exclusively for supply to: Licensed pharmaceutical importers and distributors Hospitals and specialized medical institutions Authorized clinics operating under regulated medical supervision Government healthcare procurement agencies and institutional tenders Retail sale and direct consumer distribution are strictly excluded. Regulatory & Compliance NoteBotulax 200 Units Injection contains Botulinum Toxin Type A, a controlled prescription-only biological substance. Importation, storage, distribution, and use must fully comply with the pharmaceutical regulations, licensing requirements, and medical laws of the destination country. AmeriDrugs operates solely as an export-focused pharmaceutical supplier and does not promote this product for self-administration, cosmetic retail use, or non-regulated applications.
